Rate Video

IMW 2019 | Managing CRS in myeloma

Nina Shah

IMW 2019

Multiple Myeloma

Nina Shah, MD, from the University of California, San Francisco, CA, discusses cytokine release syndrome (CRS) resulting from CAR T-cell therapy and how this can best be managed. Recorded at the International Myeloma Workshop (IMW) 2019, held in Boston, MA.

Nina Shah: highlights from EHA

Nina Shah • 8 Jun 2020

CAR T-cell therapy expectations for myeloma

Nina Shah • 14 Sep 2019

Promising results for MM treatment with natural killer cells

Nina Shah • 1 Jun 2018

T-Cell Engagers: targets, challenges and opportunity

Hermann Einsele et al. • 27 Mar 2022

Related Videos

A.R.R.O.W. study: carfilzomib dosing in frail MM patients

Maria-Victoria Mateos

Managing transplant patients during the COVID-19 pandemic

Christian Chabannon

DNA methyltransferase inhibitors: daratumumab enhancement for MM

Daratumumab enhancement for MM: the clinical impact